Computational design and high-throughput mutational scanning yield proteins with subnanomolar affinities for influenza hemagglutinin.
This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Metzker, M.L. Nat. Rev. Genet. 11, 31–46 (2010).
Araya, C. & Fowler, D.M. Trends Biotechnol. 29, 435–442 (2011).
Whitehead, T.A. et al. Nat. Biotechnol. 30, 543–548 (2012)
Wu, X. et al. Science 333, 1593–1602 (2011).
Ernst, A. et al. Mol. Biosyst. 6, 1782–1790 (2010).
Fowler, D.M. et al. Nat. Methods 7, 741–746 (2010).
Patwardhan, R.P. et al. Nat. Biotechnol. 27, 1173–1175 (2009).
Fleishman, S.J. Science 332, 816–821 (2011).
Bahadur, R.P. et al. J. Mol. Biol. 336, 943–955 (2004).
Baker, N.A. et al. Proc. Natl. Acad. Sci. USA 98, 10037–10041 (2001).
Fleishman, S.J. et al. J. Mol. Biol. 414, 289–302 (2011).
The author declares no competing financial interests.
About this article
Cite this article
Wodak, S. Next-generation protein engineering targets influenza. Nat Biotechnol 30, 502–504 (2012). https://doi.org/10.1038/nbt.2268